USA COMPRESSION PTNRS LP (USAC) Financials

USAC

Trailing 12 months to June 30, 2026

Revenue $1.2B +19.9% YoY

Net Income $146.2M +55.9% YoY

Free Cash Flow $309.8M +19.9% YoY

Operating Cash Flow $447.2M +25.1% YoY

Market Cap $3.7B as of Oct 13, 2026

Price / Sales 3.2x on $1.2B revenue, trailing 12 months to June 30, 2026

Price / Earnings 25.5x on $146.2M net income, trailing 12 months to June 30, 2026

Price / Book 13.0x on $287.1M equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 13, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Aug 6, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Aug 6, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the USAC SEC filings page.

USA COMPRESSION PTNRS LP (USAC) reported $1.2B in revenue over the twelve months to Jun 30, 2026, up 19.9% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI USAC FY2025 2026-10-03

The business converts rising revenue into cash, but its asset-heavy financing leaves liabilities above assets and equity negative.

From FY2023 to FY2025, operating margin widened from 27.4% to 30.7%. Over the same span, operating cash flow rose from $272M to $394M; that pairing suggests incremental revenue is reaching cash rather than being absorbed entirely by overhead.

In FY2025, free cash flow conversion was $277M against operating cash flow of $394M; the gap indicates reinvestment consumed a meaningful portion of internally generated cash. This is a capital-intensive model: reported profit does not become fully discretionary cash because equipment spending remains substantial.

Liabilities of $2.73B exceeded assets of $2.62B in FY2025, putting the reported balance sheet underwater on a book basis. Equity was -$113M alongside a 1.3x current ratio, separating long-term balance-sheet strain from positive reported short-term coverage.

Financial Health Signals

Financial Health Score 62/100

Scored as: Energy peer group

Scored against energy companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of USA COMPRESSION PTNRS LP's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

USA COMPRESSION PTNRS LP has an operating margin of 30.7%, meaning the company retains $31 of operating profit per $100 of revenue. This strong profitability earns a score of 85/100, reflecting efficient cost management and pricing power. This is down from 31.0% the prior year.

Growth

USA COMPRESSION PTNRS LP's revenue grew 5.0% year-over-year to $998.1M, a solid pace of expansion. This earns a growth score of 67/100.

Leverage

Liquidity

USA COMPRESSION PTNRS LP's current ratio of 1.27 indicates adequate short-term liquidity, earning a score of 47/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow

USA COMPRESSION PTNRS LP converts 27.8% of revenue into free cash flow ($277.0M). This strong cash generation earns a score of 84/100.

Returns

Piotroski F-Score Neutral

6/9

USA COMPRESSION PTNRS LP passes 6 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), 1 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Cash-Backed

3.54x

For every $1 of reported earnings, USA COMPRESSION PTNRS LP generates $3.54 in operating cash flow ($394.3M OCF vs $111.3M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage At Risk

1.64x

USA COMPRESSION PTNRS LP earns $1.64 in operating income for every $1 of interest expense ($306.5M vs $187.4M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$342.1M

YoY+36.8%

QoQ+3.3%

5Y CAGR+16.9%

10Y CAGR+18.3%

USA COMPRESSION PTNRS LP generated $342.1M in revenue in Q2 2026. This represents an increase of 36.8% from the same quarter a year earlier. Against the prior quarter it is up 3.3%.

EBITDA

$189.5M

YoY+28.5%

QoQ+6.1%

5Y CAGR+15.0%

USA COMPRESSION PTNRS LP's EBITDA was $189.5M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 28.5% from the same quarter a year earlier. Against the prior quarter it is up 6.1%.

Net Income

$45.7M

YoY+59.9%

QoQ+19.1%

5Y CAGR+76.2%

10Y CAGR+30.1%

USA COMPRESSION PTNRS LP reported $45.7M in net income in Q2 2026. This represents an increase of 59.9% from the same quarter a year earlier. Against the prior quarter it is up 19.1%.

EPS (Diluted)

Not reported for Q2 2026.

Cash & Balance Sheet

Free Cash Flow

$108.3M

YoY+7.2%

QoQ+75.1%

5Y CAGR+3.7%

10Y CAGR+14.5%

USA COMPRESSION PTNRS LP generated $108.3M in free cash flow in Q2 2026, representing cash available after capex. This represents an increase of 7.2% from the same quarter a year earlier. Against the prior quarter it is up 75.1%.

Cash & Debt

$9.5M

YoY+473800.0%

QoQ-34.7%

5Y CAGR+443.4%

10Y CAGR+105.7%

USA COMPRESSION PTNRS LP held $9.5M in cash against $2.9B in long-term debt as of Q2 2026.

Shares Outstanding

145M

YoY+18.1%

QoQ0.0%

5Y CAGR+8.3%

USA COMPRESSION PTNRS LP had 145M shares outstanding in Q2 2026. This represents an increase of 18.1% from the same quarter a year earlier. It is unchanged from the prior quarter.

Dividends Per Share

Not reported for Q2 2026.

Margins & Returns

Gross Margin

63.5%

YoY-1.9pp

QoQ-0.9pp

5Y change-7.3pp

10Y change-7.1pp

USA COMPRESSION PTNRS LP's gross margin was 63.5% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is down 1.9 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.9 percentage points.

Operating Margin

29.3%

YoY-1.3pp

QoQ+1.8pp

5Y change+6.9pp

USA COMPRESSION PTNRS LP's operating margin was 29.3% in Q2 2026, reflecting core business profitability. This is down 1.3 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.8 percentage points.

Net Margin

13.3%

YoY+1.9pp

QoQ+1.8pp

5Y change+11.6pp

10Y change+8.2pp

USA COMPRESSION PTNRS LP's net profit margin was 13.3% in Q2 2026, showing the share of revenue converted to profit. This is up 1.9 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.8 percentage points.

Return on Equity

15.9%

QoQ+3.8pp

USA COMPRESSION PTNRS LP's ROE was 15.9% in Q2 2026, measuring profit generated per dollar of shareholder equity. Against the prior quarter it is up 3.8 percentage points.

Capital Allocation

Capital Expenditures

$37.4M

YoY+61.3%

QoQ+54.2%

5Y CAGR+32.2%

10Y CAGR+15.9%

USA COMPRESSION PTNRS LP invested $37.4M in capex in Q2 2026, funding long-term assets and infrastructure. This represents an increase of 61.3% from the same quarter a year earlier. Against the prior quarter it is up 54.2%.

R&D Spending

Not reported for Q2 2026.

Share Buybacks

Not reported for Q2 2026.

USAC Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

USAC quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$1.2B	$998.1M+5.0%	$950.4M+12.3%	$846.2M+20.1%	$704.6M+11.4%	$632.6M-5.2%	$667.7M-4.4%	$698.4M+19.5%	$584.4M+111.2%	$276.7M+4.8%	$263.9M-2.4%	$270.5M+22.1%	$221.5M+44.9%	$152.9M+28.7%	$118.8M+20.3%	$98.7M
Cost of Revenue	$403.4M	$328.8M+5.1%	$312.7M+9.8%	$284.7M+21.5%	$234.3M+20.6%	$194.4M-5.6%	$205.9M-9.4%	$227.3M+5.9%	$214.7M+71.5%	$125.2M	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	$772.8M	$669.3M+5.0%	$637.7M+13.6%	$561.5M+19.4%	$470.3M+7.3%	$438.3M-5.1%	$461.7M-2.0%	$471.1M+27.4%	$369.6M+144.0%	$151.5M	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$98.8M	$66.3M-8.7%	$72.7M-0.1%	$72.7M+18.7%	$61.3M+9.3%	$56.1M-6.5%	$60.0M-6.9%	$64.4M-6.7%	$69.0M+176.6%	$24.9M+9.7%	$22.7M-44.5%	$41.0M+5.8%	$38.7M+40.3%	$27.6M+51.0%	$18.3M+43.6%	$12.7M
Operating Income	$352.3M	$306.5M+4.1%	$294.4M+26.9%	$232.0M+37.0%	$169.3M+20.2%	$140.9M+130.3%	-$464.9M-376.1%	$168.4M+157.8%	$65.3M+124.9%	-$262.7M-874.5%	-$27.0M+80.1%	-$135.6M-461.0%	$37.6M+57.6%	$23.8M+15.8%	$20.6M+56.2%	$13.2M
EBITDA	N/A	$591.3M+5.7%	$559.2M+17.0%	$478.1M+17.8%	$406.0M+6.9%	$379.6M+268.1%	-$225.9M-156.5%	$399.8M+43.3%	$279.0M+390.3%	-$96.1M-175.0%	$128.2M+354.5%	-$50.4M-146.3%	$108.7M+41.7%	$76.7M+22.9%	$62.5M+36.0%	$45.9M
Interest Expense	$190.6M	$187.4M-3.1%	$193.5M+13.9%	$169.9M+23.1%	$138.1M+6.3%	$129.8M+0.9%	$128.6M+1.2%	$127.1M+62.2%	$78.4M	$0-100.0%	$21.1M+19.8%	$17.6M+40.5%	$12.5M+0.3%	$12.5M-21.5%	$15.9M+22.6%	$13.0M
Income Tax	$12.5M	$4.9M+118.2%	$2.2M+63.4%	$1.4M+34.4%	$1.0M+16.2%	$874K-34.4%	$1.3M-39.0%	$2.2M+188.4%	-$2.5M-234.2%	$1.8M+1230.7%	-$163K-115.0%	$1.1M+953.4%	$103K-63.2%	$280K+42.9%	$196K+26.5%	$155K
Net Income	$146.2M	$111.3M+11.8%	$99.6M+45.9%	$68.3M+125.2%	$30.3M+195.0%	$10.3M+101.7%	-$594.7M-1619.8%	$39.1M+470.9%	-$10.6M+96.0%	-$264.7M-882.5%	-$26.9M+82.5%	-$154.3M	N/A	N/A	N/A	N/A

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Revenue	$342.1M+36.8%	$331.3M+35.1%	$252.5M+2.7%	$250.3M+4.3%	$250.1M+6.3%	$245.2M+7.0%	$245.9M+9.3%	$240.0M+10.5%
Cost of Revenue	$124.8M+44.3%	$117.9M+44.5%	$83.7M+7.8%	$77.0M-5.9%	$86.5M+10.7%	$81.6M+8.7%	$77.7M+6.1%	$81.8M+9.2%
Gross Profit	$217.4M+32.8%	$213.4M+30.4%	$168.7M+0.3%	$173.3M+9.6%	$163.6M+4.1%	$163.6M+6.1%	$168.2M+10.8%	$158.2M+11.3%
SG&A Expenses	$28.9M+124.1%	$35.4M+87.5%	$17.9M-11.9%	$16.7M+8.7%	$12.9M-9.0%	$18.9M-17.4%	$20.3M+9.3%	$15.4M-23.5%
Operating Income	$100.4M+31.0%	$91.4M+31.7%	$76.6M+2.7%	$83.9M+10.9%	$76.6M-1.0%	$69.4M+3.8%	$74.5M+8.7%	$75.7M+24.2%
EBITDA	$189.5M+28.5%	$178.6M+27.7%	$148.9M+3.8%	$155.2M+8.6%	$147.4M+3.3%	$139.8M+7.4%	$143.5M+9.5%	$142.9M+14.3%
Interest Expense	$49.3M+3.3%	$49.0M+3.4%	$45.3M-6.8%	$47.1M-4.6%	$47.7M-2.4%	$47.4M+1.5%	$48.6M+8.4%	$49.4M+14.1%
Income Tax	$5.5M+1301.5%	$4.1M+168.5%	$536K+6.6%	$2.4M+203.5%	$391K-15.6%	$1.5M+225.2%	$503K+41.7%	$793K+211.0%
Net Income	$45.7M+59.9%	$38.3M+86.9%	$27.8M+9.1%	$34.5M+78.4%	$28.6M-8.6%	$20.5M-13.0%	$25.4M+98.1%	$19.3M-7.5%

Not reported in any period shown, so not listed: R&D Expenses, EPS (Basic), EPS (Diluted), Diluted Shares (Avg).

USAC Balance Sheet

USAC quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$2.6B-4.6%	$2.7B+0.3%	$2.7B+2.7%	$2.7B-3.7%	$2.8B-6.1%	$2.9B-21.0%	$3.7B-1.2%	$3.8B+119.6%	$1.7B+16.7%	$1.5B-2.5%	$1.5B-0.4%	$1.5B+27.9%	$1.2B+35.9%	$872.6M	N/A
Current Assets	$236.6M+0.7%	$235.0M+3.8%	$226.4M+21.5%	$186.4M-9.0%	$205.0M+2.7%	$199.6M-13.6%	$230.9M+6.1%	$217.7M+193.5%	$74.2M+1.7%	$73.0M+37.8%	$53.0M+39.3%	$38.0M+16.0%	$32.8M+121.8%	$14.8M	N/A
Cash & Equivalents	$8.6M+61071.4%	$14K+27.3%	$11K-68.6%	$35K	$0-100.0%	$2K-80.0%	$10K-89.9%	$99K-97.5%	$4.0M-71.7%	$14.2M+26.0%	$11.3M+187433.3%	$6K-14.3%	$7K0.0%	$7K+133.3%	$3K
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$134.5M+0.4%	$133.9M+16.7%	$114.7M+22.4%	$93.8M+9.3%	$85.8M+1.4%	$84.6M-7.9%	$91.9M+3.3%	$89.0M+167.9%	$33.2M+12.4%	$29.6M+56.6%	$18.9M+111.5%	$8.9M-10.2%	$9.9M+135.8%	$4.2M	N/A
Accounts Receivable	N/A	N/A	N/A	$83.8M+22.9%	$68.2M+7.0%	$63.7M-20.6%	$80.3M+6.2%	$75.6M+131.1%	$32.7M+1.4%	$32.2M+13.3%	$28.5M+13.1%	$25.2M+25.3%	$20.1M+133.0%	$8.6M	N/A
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$0	N/A	N/A	N/A	N/A	$0-100.0%	$619.4M0.0%	$619.4M+144.4%	$253.4M+606.6%	$35.9M0.0%	$35.9M-82.8%	$208.1M0.0%	$208.1M+32.5%	$157.1M	N/A
Total Liabilities	$2.7B+0.5%	$2.7B+6.4%	$2.6B+10.8%	$2.3B+5.3%	$2.2B+2.6%	$2.1B+3.0%	$2.1B+8.0%	$1.9B+3447.3%	$54.1M	N/A	N/A	N/A	N/A	N/A	N/A
Current Liabilities	$186.9M-2.0%	$190.7M+1.7%	$187.5M+8.0%	$173.7M-7.5%	$187.6M+10.2%	$170.3M-10.1%	$189.4M+26.6%	$149.6M+217.7%	$47.1M-16.5%	$56.4M-8.2%	$61.4M-25.2%	$82.1M+44.2%	$57.0M+112.1%	$26.9M	N/A
Non-Current Liabilities	$2.5B+0.7%	$2.5B+6.8%	$2.4B+11.0%	$2.1B+6.5%	$2.0B+2.0%	$2.0B+4.3%	$1.9B+6.5%	$1.8B+25205.9%	$7.0M	N/A	N/A	N/A	N/A	N/A	N/A
Long-Term Debt	$2.5B+0.9%	$2.5B+7.1%	$2.3B+10.9%	$2.1B+6.8%	$2.0B+2.4%	$1.9B+4.0%	$1.9B+5.3%	$1.8B	N/A	$685.4M-6.0%	$729.2M+22.6%	$594.9M+41.3%	$420.9M-16.2%	$502.3M	N/A
Total Equity	-$112.5M-505.3%	$27.8M-84.8%	$183.0M-49.3%	$361.0M-37.6%	$578.4M-29.0%	$815.0M-50.8%	$1.7B-10.7%	$1.9B+11.5%	$1.7B	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Total Assets	$3.7B+38.0%	$3.7B+37.6%	$2.6B-4.6%	$2.7B-5.2%	$2.7B-5.3%	$2.7B-3.2%	$2.7B+0.3%	$2.8B+3.6%
Current Assets	$323.0M+31.8%	$346.8M+42.6%	$236.6M+0.7%	$251.6M-4.1%	$245.0M-4.2%	$243.3M-2.2%	$235.0M+3.8%	$262.4M+17.3%
Cash & Equivalents	$9.5M+473800.0%	$14.5M+726000.0%	$8.6M+61071.4%	$0-100.0%	$2K-77.8%	$2K-75.0%	$14K+27.3%	$79K+1216.7%
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$159.4M+17.6%	$154.4M+14.9%	$134.5M+0.4%	$137.4M-6.4%	$135.6M+3.3%	$134.3M+3.9%	$133.9M+16.7%	$146.8M+37.9%
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$117.4M	$117.4M	$0	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$3.4B+25.0%	$3.4B+25.4%	$2.7B+0.5%	$2.7B-0.2%	$2.7B+0.2%	$2.7B+2.4%	$2.7B+6.4%	$2.7B+10.6%
Current Liabilities	$240.1M+24.5%	$224.2M+35.1%	$186.9M-2.0%	$184.8M+0.9%	$192.9M-5.7%	$166.0M-4.4%	$190.7M+1.7%	$183.1M+3.1%
Non-Current Liabilities	$3.2B+25.0%	$3.2B+24.8%	$2.5B+0.7%	$2.6B-0.3%	$2.5B+0.7%	$2.6B+2.8%	$2.5B+6.8%	$2.6B+11.2%
Long-Term Debt	$2.9B+17.5%	$3.0B+17.5%	$2.5B+0.9%	$2.5B-0.1%	$2.5B+0.8%	$2.5B+3.0%	$2.5B+7.1%	$2.5B+11.2%
Total Equity	$287.1M+697.9%	$316.7M+2760.6%	-$112.5M-505.3%	-$76.8M-224.8%	-$48.0M-144.6%	-$11.9M-108.4%	$27.8M-84.8%	$61.6M-72.8%

Not reported in any period shown, so not listed: Accounts Receivable, Retained Earnings.

USAC Cash Flow Statement

USAC quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	$447.2M	$394.3M+15.5%	$341.3M+25.5%	$271.9M+4.3%	$260.6M-1.8%	$265.4M-9.5%	$293.2M-2.5%	$300.6M+32.8%	$226.3M+66.5%	$136.0M+4.5%	$130.1M+10.8%	$117.4M+15.2%	$101.9M+49.4%	$68.2M+62.5%	$42.0M+24.2%	$33.8M
Depreciation & Amortization	N/A	$284.8M+7.6%	$264.8M+7.6%	$246.1M+4.0%	$236.7M-0.9%	$238.8M-0.1%	$239.0M+3.2%	$231.4M+8.3%	$213.7M+28.3%	$166.6M+7.4%	$155.1M+82.0%	$85.2M+19.8%	$71.2M+34.5%	$52.9M+26.4%	$41.9M+27.9%	$32.7M
Stock-Based Compensation	N/A	$4.3M-73.8%	$16.6M-25.3%	$22.2M+39.5%	$15.9M+2.4%	$15.5M+84.8%	$8.4M-22.3%	$10.8M-7.9%	$11.7M+190.0%	$4.0M+14.4%	$3.5M-8.4%	$3.9M+27.3%	$3.0M+125.9%	$1.3M	N/A	N/A
Capital Expenditures	$137.3M	$117.3M-42.8%	$204.9M-14.1%	$238.5M+77.7%	$134.2M+196.9%	$45.2M-58.5%	$109.1M-36.3%	$171.1M-35.8%	$266.6M+69.5%	$157.3M+155.4%	$61.6M-78.1%	$281.1M-26.4%	$381.9M+139.4%	$159.5M-11.4%	$180.0M+35.1%	$133.3M
Free Cash Flow	$309.8M	$277.0M+102.9%	$136.5M+309.1%	$33.4M-73.6%	$126.4M-42.6%	$220.2M+19.6%	$184.1M+42.3%	$129.4M+421.8%	-$40.2M-88.5%	-$21.3M-131.2%	$68.5M+141.9%	-$163.6M+41.6%	-$280.1M-206.5%	-$91.4M+33.8%	-$138.0M-38.7%	-$99.5M
Investing Cash Flow	-$577.4M	-$115.0M+43.1%	-$202.0M+13.2%	-$232.7M-79.0%	-$129.9M-231.6%	-$39.2M+62.7%	-$105.1M+27.3%	-$144.5M+81.5%	-$779.7M-447.3%	-$142.5M-287.5%	-$36.8M+86.8%	-$278.2M	N/A	N/A	N/A	N/A
Financing Cash Flow	$139.8M	-$270.8M-94.3%	-$139.3M-254.9%	-$39.3M+69.9%	-$130.6M+42.3%	-$226.2M-20.3%	-$188.1M-20.4%	-$156.2M-128.4%	$549.4M+15086.6%	-$3.7M+95.9%	-$90.4M-156.2%	$160.8M	N/A	N/A	N/A	N/A

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Operating Cash Flow	$145.7M+17.3%	$86.1M+57.6%	$139.5M+7.1%	$75.9M+56.5%	$124.2M+28.4%	$54.7M-17.1%	$130.2M+42.1%	$48.5M-3.2%
Depreciation & Amortization	$89.1M+25.7%	$87.1M+23.8%	$72.4M+4.9%	$71.2M+5.9%	$70.8M+8.5%	$70.4M+11.3%	$69.0M+10.4%	$67.2M+4.9%
Stock-Based Compensation	N/A	$2.4M-28.9%	N/A	N/A	N/A	$3.4M-56.4%	N/A	N/A
Capital Expenditures	$37.4M+61.3%	$24.2M+32.0%	$51.7M+78.3%	$24.0M-16.4%	$23.2M-52.3%	$18.4M-81.4%	$29.0M-63.5%	$28.7M-45.5%
Free Cash Flow	$108.3M+7.2%	$61.9M+70.5%	$87.7M-13.3%	$51.9M+162.1%	$101.1M+109.7%	$36.3M+211.0%	$101.2M+734.1%	$19.8M+869.0%
Investing Cash Flow	-$35.0M-56.5%	-$467.9M-2493.5%	-$51.2M-90.1%	-$23.4M+17.6%	-$22.4M+53.6%	-$18.0M+81.7%	-$26.9M+66.0%	-$28.4M+41.0%
Financing Cash Flow	-$115.8M-13.6%	$387.7M+1158.8%	-$79.7M+22.8%	-$52.5M-162.1%	-$101.9M-109.7%	-$36.6M-212.2%	-$103.3M-737.6%	-$20.0M-894.1%

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

USAC Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

USAC quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Gross Margin	67.1%0.0pp	67.1%+0.8pp	66.3%-0.4pp	66.7%-2.5pp	69.3%+0.1pp	69.2%+1.7pp	67.5%+4.2pp	63.2%+8.5pp	54.8%	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	30.7%-0.3pp	31.0%+3.6pp	27.4%+3.4pp	24.0%+1.8pp	22.3%+91.9pp	-69.6%-93.7pp	24.1%+12.9pp	11.2%+106.1pp	-94.9%-84.7pp	-10.2%+39.9pp	-50.1%-67.1pp	17.0%+1.4pp	15.6%-1.7pp	17.3%+4.0pp	13.3%
Net Margin	11.2%+0.7pp	10.5%+2.4pp	8.1%+3.8pp	4.3%+2.7pp	1.6%+90.7pp	-89.1%-94.7pp	5.6%+7.4pp	-1.8%+93.9pp	-95.7%-85.5pp	-10.2%+46.8pp	-57.0%	N/A	N/A	N/A	N/A
Return on Equity	N/A	358.7%+321.4pp	37.3%+28.9pp	8.4%+6.6pp	1.8%+74.8pp	-73.0%-75.3pp	2.4%+2.9pp	-0.6%+15.3pp	-15.9%	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets	4.3%+0.6pp	3.6%+1.1pp	2.5%+1.3pp	1.1%+0.8pp	0.4%+20.5pp	-20.2%-21.2pp	1.1%+1.3pp	-0.3%+15.1pp	-15.4%-13.6pp	-1.8%+8.4pp	-10.2%	N/A	N/A	N/A	N/A
Current Ratio	1.270.0x	1.230.0x	1.21+0.1x	1.070.0x	1.09-0.1x	1.170.0x	1.22-0.2x	1.46-0.1x	1.58+0.3x	1.29+0.4x	0.86+0.4x	0.46-0.1x	0.580.0x	0.55	N/A
Debt-to-Equity	N/A	90.16+77.4x	12.76+6.9x	5.84+2.4x	3.41+1.0x	2.36+1.2x	1.12+0.2x	0.95+0.9x	0.03	N/A	N/A	N/A	N/A	N/A	N/A
Asset Turnover	0.380.0x	0.350.0x	0.310.0x	0.260.0x	0.230.0x	0.230.0x	0.190.0x	0.150.0x	0.160.0x	0.180.0x	0.180.0x	0.150.0x	0.130.0x	0.14	N/A
FCF Margin	27.8%+13.4pp	14.4%+10.4pp	3.9%-14.0pp	17.9%-16.9pp	34.8%+7.2pp	27.6%+9.0pp	18.5%+25.4pp	-6.9%+0.8pp	-7.7%-33.7pp	25.9%+86.4pp	-60.5%	-126.4%	-59.7%	-116.2%	-100.8%

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Gross Margin	63.5%-1.9pp	64.4%-2.3pp	66.8%-1.6pp	69.3%+3.3pp	65.4%-1.4pp	66.7%-0.5pp	68.4%+0.9pp	65.9%+0.4pp
Operating Margin	29.3%-1.3pp	27.6%-0.7pp	30.3%0.0pp	33.5%+2.0pp	30.6%-2.2pp	28.3%-0.9pp	30.3%-0.2pp	31.5%+3.5pp
Net Margin	13.3%+1.9pp	11.6%+3.2pp	11.0%+0.6pp	13.8%+5.7pp	11.4%-1.9pp	8.4%-1.9pp	10.3%+4.6pp	8.1%-1.6pp
Return on Equity	15.9%	12.1%	N/A	N/A	N/A	N/A	91.6%+84.6pp	31.4%+22.2pp
Return on Assets	1.2%+0.2pp	1.0%+0.3pp	1.1%+0.1pp	1.3%+0.6pp	1.1%0.0pp	0.8%-0.1pp	0.9%+0.5pp	0.7%-0.1pp
Current Ratio	1.35+0.1x	1.55+0.1x	1.270.0x	1.36-0.1x	1.270.0x	1.470.0x	1.230.0x	1.43+0.2x
Debt-to-Equity	10.25	9.41	N/A	N/A	N/A	N/A	90.16+77.4x	41.14+31.1x
Asset Turnover	0.090.0x	0.090.0x	0.100.0x	0.090.0x	0.090.0x	0.090.0x	0.090.0x	0.090.0x
FCF Margin	31.7%-8.8pp	18.7%+3.9pp	34.8%-6.4pp	20.7%+12.5pp	40.4%+19.9pp	14.8%+29.1pp	41.1%+35.8pp	8.3%+9.4pp

Note: Shareholder equity is negative (-$112.5M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
USA COMPRESSION PTNRS LP USAC	FY2025	$998.1M	$111.3M	11.2%	$3.7B	62/100
Kodiak Gas Services, Inc. KGS	FY2025	$1.3B	$80.5M	6.2%	$5.3B	58/100
Tidewater, Inc. TDW	FY2025	$1.4B	$333.5M	24.6%	$4.3B	74/100
Cactus, Inc. WHD	FY2025	$1.1B	$166.0M	15.4%	$4.4B	66/100
Oceaneering International Inc. OII	FY2025	$2.8B	$353.8M	12.7%	$4.4B	69/100
Archrock Inc AROC	FY2025	$1.5B	$322.3M	21.6%	$5.3B	38/100

Where USA COMPRESSION PTNRS LP Ranks

Frequently Asked Questions

What is USA COMPRESSION PTNRS LP's annual revenue?

USA COMPRESSION PTNRS LP (USAC) reported $998.1M in total revenue for fiscal year 2025. This represents a 5.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is USA COMPRESSION PTNRS LP's revenue growing?

USA COMPRESSION PTNRS LP (USAC) revenue grew by 5.0% year-over-year, from $950.4M to $998.1M in fiscal year 2025.

Is USA COMPRESSION PTNRS LP profitable?

Yes, USA COMPRESSION PTNRS LP (USAC) reported a net income of $111.3M in fiscal year 2025, with a net profit margin of 11.2%.

What is USA COMPRESSION PTNRS LP's EBITDA?

USA COMPRESSION PTNRS LP (USAC) had EBITDA of $591.3M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does USA COMPRESSION PTNRS LP have?

As of fiscal year 2025, USA COMPRESSION PTNRS LP (USAC) had $8.6M in cash and equivalents against $2.5B in long-term debt.

What is USA COMPRESSION PTNRS LP's gross margin?

USA COMPRESSION PTNRS LP (USAC) had a gross margin of 67.1% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is USA COMPRESSION PTNRS LP's operating margin?

USA COMPRESSION PTNRS LP (USAC) had an operating margin of 30.7% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is USA COMPRESSION PTNRS LP's net profit margin?

USA COMPRESSION PTNRS LP (USAC) had a net profit margin of 11.2% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is USA COMPRESSION PTNRS LP's free cash flow?

USA COMPRESSION PTNRS LP (USAC) generated $277.0M in free cash flow during fiscal year 2025. This represents a 102.9% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is USA COMPRESSION PTNRS LP's operating cash flow?

USA COMPRESSION PTNRS LP (USAC) generated $394.3M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are USA COMPRESSION PTNRS LP's total assets?

USA COMPRESSION PTNRS LP (USAC) had $2.6B in total assets as of fiscal year 2025, including both current and long-term assets.

What are USA COMPRESSION PTNRS LP's capital expenditures?

USA COMPRESSION PTNRS LP (USAC) invested $117.3M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How many shares does USA COMPRESSION PTNRS LP have outstanding?

USA COMPRESSION PTNRS LP (USAC) had 145M shares outstanding as of fiscal year 2025.

What is USA COMPRESSION PTNRS LP's current ratio?

USA COMPRESSION PTNRS LP (USAC) had a current ratio of 1.27 as of fiscal year 2025, which is considered adequate.

What is USA COMPRESSION PTNRS LP's return on assets (ROA)?

USA COMPRESSION PTNRS LP (USAC) had a return on assets of 4.3% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is USA COMPRESSION PTNRS LP's P/E ratio?

USA COMPRESSION PTNRS LP (USAC) trades at 25.5x earnings, its market capitalization divided by net income of $146.2M net income, trailing 12 months to June 30, 2026. The market capitalization is $3.7B as of Oct 13, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is USA COMPRESSION PTNRS LP's price-to-sales ratio?

USA COMPRESSION PTNRS LP (USAC) trades at 3.2x sales, its market capitalization divided by revenue of $1.2B revenue, trailing 12 months to June 30, 2026. The market capitalization is $3.7B as of Oct 13, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Why is USA COMPRESSION PTNRS LP's debt-to-equity ratio negative or not reported?

USA COMPRESSION PTNRS LP (USAC) has negative shareholder equity of -$112.5M as of fiscal year 2025, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

What is USA COMPRESSION PTNRS LP's Piotroski F-Score?

USA COMPRESSION PTNRS LP (USAC) has a Piotroski F-Score of 6 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are USA COMPRESSION PTNRS LP's earnings high quality?

USA COMPRESSION PTNRS LP (USAC) has an earnings quality ratio of 3.54x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can USA COMPRESSION PTNRS LP cover its interest payments?

USA COMPRESSION PTNRS LP (USAC) has an interest coverage ratio of 1.64x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is USA COMPRESSION PTNRS LP?

USA COMPRESSION PTNRS LP (USAC) scores 62 out of 100 on our Financial Health Score, indicating moderate standing within its energy companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.